| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| apg-115 | ubiquitin-protein ligase e3 mdm2 | NA | Clinical trial target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Malignant Neoplasms[MeSHID:D009369] Prolymphocytic Leukemia[MeSHID:D015463] |
NA | phase 2 | unknown |
| apg-115 | cellular tumor antigen p53 | NA | Clinical trial target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Malignant Neoplasms[MeSHID:D009369] Prolymphocytic Leukemia[MeSHID:D015463] |
NA | phase 2 | unknown |
| click here to return to the previous page | ||||||||